Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

49 projects found matching your search criteria :

  1. Estrogen receptor GPER as a modulator of inflammatory and functional gastrointestinal diseases and colorectal cancer

    Call: PRELUDIUM 9 , Panel: NZ5

    Principal investigator: Damian Jacenik

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

  2. Non-quinazoline antagonists of apha1 and 5-HT2A receptors with pleiotropic effects as a new perspective for hypertension...

    Call: SONATA 8 , Panel: NZ7

    Principal investigator: dr Monika Kubacka

    Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

  3. New selective antagonists of ionotropic glutamate non-NMDA receptors

    Call: OPUS 8 , Panel: NZ7

    Principal investigator: dr Ewa Szymańska

    Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

  4. Design and synthesis of phosphoroorganic antagonists of BIR domain of apoptosis inhibitor proteins (IAP)

    Call: PRELUDIUM 7 , Panel: ST5

    Principal investigator: dr Agnieszka Łupicka-Słowik

    Politechnika Wrocławska, Wydział Chemiczny

  5. Synthesis and marking the activity of new potential antagonists of receptors for excitatory amino acids which have the s...

    Call: OPUS 1 , Panel: NZ4

    Principal investigator: prof. Aleksander Mazurek

    Warszawski Uniwersytet Medyczny, Wydział Farmaceutyczny

  6. Influence of antagonists (scopolamine and 3-quinuclidinyl benzilate) and agosists (carbachol) of muscarinic cholinergic ...

    Call: PRELUDIUM 5 , Panel: NZ9

    Principal investigator: Szymon Chowański

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Biologii

  7. The effect of cytoplasmic incompatibility inducing Wolbachia on the detection of intralocus sexual conflict

    Call: PRELUDIUM 5 , Panel: NZ8

    Principal investigator: Eoin Duffy

    Uniwersytet Jagielloński, Wydział Biologii i Nauk o Ziemi

  8. Interactions between isolates of Potato virus Y (PVY) in mixed infections and their effects on the spatial distribution ...

    Call: OPUS 5 , Panel: NZ9

    Principal investigator: dr hab. Jerzy Syller

    Instytut Hodowli i Aklimatyzacji Roślin - Państwowy Instytut Badawczy

  9. Structural studies based on low sequence similarity of G protein-coupled receptors activated by hormones and allosteric ...

    Call: SONATA 4 , Panel: NZ1

    Principal investigator: dr Dorota Latek

    Uniwersytet Warszawski, Wydział Chemii

  10. Studies on synergistic effects of selected phenols and polyphenols during peroxidation of model lipid systems.

    Call: PRELUDIUM 3 , Panel: ST4

    Principal investigator: Ewelina van Wenum

    Uniwersytet Warszawski, Wydział Chemii

  11. LCAP biomimetics - alicyclic amine derivatives as a new class of monoaminergic receptor ligands

    Call: OPUS 3 , Panel: NZ7

    Principal investigator: dr hab. Paweł Zajdel

    Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

  12. Structure-activity relationship of bifunctional peptides, agonists of opioid receptors and antagonists of neurokinin rec...

    Call: PRELUDIUM 2 , Panel: ST5

    Principal investigator: Jolanta Dyniewicz

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  13. Conjugated linoleic acid (CLA)-induced transcriptional activation of PPAR-an investigation of molecular machanisms of pu...

    Call: OPUS 2 , Panel: NZ9

    Principal investigator: prof. Teresa Leszczyńska

    Uniwersytet Rolniczy im. Hugona Kołłątaja w Krakowie, Wydział Technologii Żywności

  14. Analysis of the anti-nociceptive and anti-inflammatory action of histamine H4 receptor antagonist in inflammatory nocice...

    Call: PRELUDIUM 2 , Panel: NZ4

    Principal investigator: Przemysław Rzodkiewicz

    Instytut Reumatologii im. prof. dr hab. med. Eleonory Reicher

  15. Brain regions that mediate antipsychotic-induced changes in oscillatory activity recorded in the nucleus accumbens

    Call: OPUS 2 , Panel: NZ4

    Principal investigator: dr Mark Hunt

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

  16. Targeting the serotonin 5-HT7 receptor in a search for new strategies of mental disorders treatment

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Patryk Pyka

    Uniwersytet Jagielloński, Collegium Medicum

  17. The role of simultaneous and individual modulation of μ-opioid, sigma-1 and histamine H3 receptors as a new therapeutic ...

    Call: OPUS 23 , Panel: NZ7

    Principal investigator: dr Katarzyna Szczepańska

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  18. The evaluation of therapeutic potential of β-caryophyllene in animal schizophrenia model - behavioral and molecular stud...

    Call: PRELUDIUM 21 , Panel: NZ7

    Principal investigator: Magdalena Białoń

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  19. Dual 5-HT3 receptor/5-HT6 receptor antagonists in neuropsychiatric and neurological disorders

    Call: OPUS 22 , Panel: NZ7

    Principal investigator: prof. Paweł Zajdel

    Uniwersytet Jagielloński, Collegium Medicum

  20. Opioid receptors in the basal ganglia of the brain as targets for alcohol abuse therapy.

    Call: OPUS 2 , Panel: NZ4

    Principal investigator: dr Jan Rodriguez Parkitna

    Instytut Farmakologii PAN

  21. The SAR analysis and synthesis of complex, small molecule PD-1/PD-L1 interaction antagonists

    Call: PRELUDIUM 20 , Panel: ST4

    Principal investigator: Magdalena Żarnik

    Uniwersytet Jagielloński, Wydział Chemii

  22. Self-learning systems in the design of compounds modulating GPCR receptors activation.

    Call: OPUS 20 , Panel: NZ2

    Principal investigator: dr hab. Dorota Latek

    Uniwersytet Warszawski, Wydział Chemii

  23. Quinoxalino-2,3-diones as potent tools for exploration of ionotropic kainate receptors

    Call: OPUS 20 , Panel: NZ7

    Principal investigator: dr hab. Ewa Szymańska

    Uniwersytet Jagielloński, Collegium Medicum

  24. Combined administration of muscarinic receptor antagonists and group II/III metabotropic glutamate (mGlu) receptor ligan...

    Call: OPUS 19 , Panel: NZ7

    Principal investigator: prof. Andrzej Pilc

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  25. Histamine H3/H4 receptors as the attractive target for the search of biologically active substances

    Call: MAESTRO 1 , Panel: NZ4

    Principal investigator: prof. Katarzyna Kieć-Kononowicz

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

  26. Evaluation of the activity of MDM2-p53 antagonist RG7388 in mouse cancer models, alone and in combination with anti-PD-1...

    Call: PRELUDIUM 18 , Panel: NZ5

    Principal investigator: Aneta Wiśniewska

    Uniwersytet Jagielloński, Wydział Chemii

  27. Clinical efficacy of pharmacotherapy with antihistaminics and leukotriene antagonists and the therapy impact on cyclooxy...

    Call: PRELUDIUM 1 , Panel: NZ5

    Principal investigator: Paulina Korczyńska

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  28. Quantitative assessment of vascular endothelial growth factor (VEGF) in serum, follicular fluid (FF) and VEGF mRNA in gr...

    Call: OPUS 1 , Panel: NZ5

    Principal investigator: prof. Artur Jakimiuk

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  29. Co-crystallization and co-amorphization of angiotensin II receptor blockers leading to more soluble compounds with a bif...

    Call: PRELUDIUM 17 , Panel: ST5

    Principal investigator: Marika Turek

    Uniwersytet Humanistyczno-Przyrodniczy im. Jana Długosza w Częstochowie

  30. The assessment of cysteinyl leukotriene receptor antagonist role in inhibition of atherosclerosis, proliferation and its...

    Call: OPUS 17 , Panel: NZ5

    Principal investigator: dr hab. Paweł Maga

    Uniwersytet Jagielloński, Collegium Medicum

  31. Neuroprotective properties of 5-HT6 receptor ligands in the group of 2-arylpyrrole derivatives – a new insight into neur...

    Call: PRELUDIUM 17 , Panel: NZ7

    Principal investigator: Marcin Drop

    Uniwersytet Jagielloński, Collegium Medicum

  32. Application of machine learning based artificial intelligence to search for substances that modulate the activity of ROR...

    Call: OPUS 17 , Panel: NZ7

    Principal investigator: dr hab. Marcin Ratajewski

    Instytut Biologii Medycznej Polskiej Akademii Nauk

  33. Połączone działanie agonistów receptorów adenozynowych i antagonistów receptora P2Y12 zwiększa hamowanie funkcji płytek ...

    Call: ETIUDA 7 , Panel: NZ3

    Principal investigator: Nina Wolska

    Uniwersytet Medyczny w Łodzi, Wydział Nauk o Zdrowiu

  34. Prognostic value of platelet-derived microRNAs in patients with acute coronary syndrome treated with novel P2Y12 recepto...

    Call: PRELUDIUM 16 , Panel: NZ7

    Principal investigator: dr hab. Aleksandra Gąsecka-van der Pol

    Warszawski Uniwersytet Medyczny, I Wydział Lekarski

  35. Development of macrocyclic peptide antagonists of the PD-1/PD-L1 pathway. Charcterization of simultaneous administration...

    Call: SONATA 14 , Panel: NZ7

    Principal investigator: dr Katarzyna Magiera-Mularz

    Uniwersytet Jagielloński, Wydział Chemii

  36. Social interaction between Bacillus subtilis and Dickeya solani

    Call: OPUS 15 , Panel: NZ9

    Principal investigator: prof. Michał Obuchowski

    Gdański Uniwersytet Medyczny, Międzyuczelniany Wydział Biotechnologii Uniwersytetu Gdańskiego i Gdańskiego Uniwersytetu Medycznego

  37. Non-vitamin K antagonist oral anticoagulants (NOACs) as modulators of valvular calcification and inflammation in aortic ...

    Call: OPUS 15 , Panel: NZ5

    Principal investigator: dr hab. Joanna Natorska

    Krakowski Szpital Specjalistyczny im. św. Jana Pawła II

  38. Multifunctional ligands - TRPA1 channel antagonists and phosphodiesterases inhibitors as a new approach for the treatmen...

    Call: OPUS 15 , Panel: NZ7

    Principal investigator: dr hab. Grażyna Chłoń-Rzepa

    Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

  39. New vanilloid type 1 receptor (TRPV1) antagonists in the search for substances with wide-spectrum of anticonvulsant and ...

    Call: OPUS 14 , Panel: NZ7

    Principal investigator: dr hab. Krzysztof Kamiński

    Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

  40. Radiopharmaceuticals based on neurokinin-1 receptor antagonists for the diagnosis and therapy of a brain tumour - gliobl...

    Call: OPUS 13 , Panel: NZ7

    Principal investigator: prof. Aleksandra Misicka-Kęsik

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego Polskiej Akademii Nauk

  41. New mulitple target-directed ligands - A1/A2A adenosine receptors antagonists and monoamine oxidase B inhibitors - searc...

    Call: PRELUDIUM 12 , Panel: NZ7

    Principal investigator: Michał Załuski

    Uniwersytet Jagielloński, Collegium Medicum, Wydział Farmaceutyczny

  42. Piperazine derivatives as active histamine H3 receptor ligands - molecular modeling, synthesis, pharmacological evaluati...

    Call: PRELUDIUM 12 , Panel: NZ7

    Principal investigator: Katarzyna Szczepańska

    Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

  43. Novel multi-target directed ligands combining cholinesterase inhibition and 5-HT6 antagonism - design, synthesis and pha...

    Call: SONATA 12 , Panel: NZ7

    Principal investigator: dr hab. Anna Więckowska

    Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

  44. Old drugs - new perspectives: modulation of antibiotics activity by caffeine and pentoxifylline

    Call: SONATA 11 , Panel: NZ7

    Principal investigator: dr Anna Woziwodzka

    Uniwersytet Gdański, Międzyuczelniany Wydział Biotechnologii Uniwersytetu Gdańskiego i Gdańskiego Uniwersytetu Medycznego

  45. Molecular receptors as a tool for studies of interactions agonist/antagonist of H1 - H4 receptors

    Call: PRELUDIUM 11 , Panel: ST5

    Principal investigator: Małgorzata Walczak

    Politechnika Łódzka, Wydział Chemiczny

  46. Characterization and improvement of anti-cancer properties of second generation antagonists of Mdm2 oncoprotein

    Call: SONATA 11 , Panel: NZ7

    Principal investigator: dr Łukasz Skalniak

    Uniwersytet Jagielloński, Wydział Chemii

  47. 5-HT6 receptor ligands as addition to antipsychotic therapy in schizophrenia - an impact on body weight, metabolic param...

    Call: OPUS 10 , Panel: NZ7

    Principal investigator: prof. Anna Wesołowska

    Uniwersytet Jagielloński Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

  48. Synthesis of new glutamate receptors antagonists and extensive investigation of their effect on tumor cells in the prese...

    Call: OPUS 9 , Panel: ST5

    Principal investigator: prof. Maria Bretner

    Politechnika Warszawska, Wydział Chemiczny

  49. Development of a method for the structure prediction of GPCRs complexes with agonists and antagonists, including the lig...

    Call: SONATA 1 , Panel: NZ2

    Principal investigator: dr Michał Koliński

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN